Celgene PE Ratio 2006-2018 | CELG

Current and historical price to earnings ratio for Celgene (CELG) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Celgene PE ratio as of September 18, 2018 is 12.31.
Celgene Annual PE Ratio
Celgene Quarterly PE Ratio
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $61.622B $13.003B
Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Their portfolio of commercial products include REVLIMID, VIDAZA, THALOMID, POMALYST/IMNOVID, ABRAXANE, OTEZLA, ISTODAX and IDHIFA. The drug candidates in their pipeline are at various stages of preclinical and clinical development. These candidates include their IMiDs compounds, which are a proprietary class of compounds that have certain immunomodulatory and other biologically important properties in addition to their leading oral anti-inflammatory agents and cellular therapies. They believe their commercial stage products and the depth of their product pipeline, provide the catalysts for future growth.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $130.969B 15.03
Gilead Sciences (GILD) United States $95.501B 10.60
Biogen (BIIB) United States $67.864B 14.39
Illumina (ILMN) United States $51.579B 64.62
Vertex Pharmaceuticals (VRTX) United States $45.265B 102.98
Regeneron Pharmaceuticals (REGN) United States $41.961B 23.59
Alexion Pharmaceuticals (ALXN) United States $26.926B 20.24
BioMarin Pharmaceutical (BMRN) United States $17.681B 0.00
Incyte (INCY) United States $14.417B 484.43
Seattle Genetics (SGEN) United States $12.340B 0.00
Sarepta Therapeutics (SRPT) United States $10.204B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.437B 0.00
Exact Sciences (EXAS) United States $8.932B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.881B 57.03
QIAGEN (QGEN) Netherlands $8.700B 28.45
BeiGene (BGNE) Cayman Islands $8.643B 0.00
Bluebird Bio (BLUE) United States $7.582B 0.00
Bio-Techne Corp (TECH) United States $7.452B 49.84
Alkermes (ALKS) Ireland $6.062B 0.00
Galapagos (GLPG) Belgium $5.968B 0.00
Ligand Pharmaceuticals (LGND) United States $5.608B 49.67
Exelixis (EXEL) United States $4.968B 16.18
Ultragenyx Pharmaceutical (RARE) United States $4.266B 0.00
Immunomedics (IMMU) United States $4.183B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.566B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.410B 0.00
Myriad Genetics (MYGN) United States $3.383B 37.86
Emergent Biosolutions (EBS) United States $3.290B 26.20
Horizon Pharma Public (HZNP) Ireland $3.208B 18.16
Array BioPharma (ARRY) United States $3.124B 0.00
Blueprint Medicines (BPMC) United States $3.114B 0.00
Ascendis Pharma (ASND) Denmark $2.838B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.809B 0.00
China Biologic Products (CBPO) China $2.717B 17.94
Reata Pharmaceuticals (RETA) United States $2.671B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.531B 0.00
Repligen (RGEN) United States $2.515B 84.44
Acceleron Pharma (XLRN) United States $2.486B 0.00
Medicines (MDCO) United States $2.484B 0.00
Halozyme Therapeutics (HALO) United States $2.479B 33.04
Genomic Health (GHDX) United States $2.422B 135.10
MyoKardia (MYOK) United States $2.397B 0.00
REGENXBIO (RGNX) United States $2.331B 36.62
Akcea Therapeutics (AKCA) United States $2.272B 0.00
Amicus Therapeutics (FOLD) United States $2.230B 0.00
Spark Therapeutics (ONCE) United States $2.181B 0.00
Global Blood Therapeutics (GBT) United States $2.145B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.134B 0.00
AnaptysBio (ANAB) United States $2.117B 0.00
G1 THERAPEUTICS (GTHX) United States $2.102B 0.00
Arena Pharmaceuticals (ARNA) United States $2.075B 0.00
Cambrex (CBM) United States $2.069B 16.59
Denali Therapeutics (DNLI) United States $1.943B 0.00
Allakos (ALLK) United States $1.891B 0.00
Atara Biotherapeutics (ATRA) United States $1.800B 0.00
ACADIA Pharmaceuticals (ACAD) United States $1.785B 0.00
Puma Biotechnology (PBYI) United States $1.778B 0.00
Mirati Therapeutics (MRTX) United States $1.764B 0.00
Solid Biosciences (SLDB) United States $1.753B 0.00
Rubius Therapeutics (RUBY) United States $1.731B 0.00
Myovant Sciences (MYOV) United Kingdom $1.705B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.699B 0.00
Clovis Oncology (CLVS) United States $1.695B 0.00
Aimmune Therapeutics (AIMT) United States $1.619B 0.00
Editas Medicine (EDIT) United States $1.565B 0.00
Sangamo Therapeutics (SGMO) United States $1.545B 0.00
Innoviva (INVA) United States $1.532B 9.84
Insmed (INSM) United States $1.498B 0.00
Audentes Therapeutics (BOLD) United States $1.495B 0.00
UniQure (QURE) Netherlands $1.482B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.481B 0.00
WAVE Life Sciences (WVE) Singapore $1.469B 0.00
Intellia Therapeutics (NTLA) United States $1.382B 0.00
DBV Technologies (DBVT) France $1.379B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.364B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.359B 0.00
IMMURON LTD (IMRN) Australia $1.329B 0.00
Lion Biotechnologies (IOVA) United States $1.310B 0.00
Cellectis (CLLS) France $1.189B 0.00
Retrophin (RTRX) United States $1.183B 0.00
Viking Therapeutics (VKTX) United States $1.180B 0.00
NeoGenomics (NEO) United States $1.163B 203.57
Lexicon Pharmaceuticals (LXRX) United States $1.163B 0.00
Coherus BioSciences (CHRS) United States $1.160B 0.00
Intra-Cellular Therapies (ITCI) United States $1.152B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.127B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.116B 0.00
Athenex (ATNX) United States $1.091B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.087B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.084B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.058B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.046B 0.00
Apellis Pharmaceuticals (APLS) United States $1.024B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.019B 1945.00
Geron (GERN) United States $1.008B 0.00
AVROBIO (AVRO) United States $0.993B 0.00
Aptinyx (APTX) United States $0.964B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.904B 0.00
Revance Therapeutics (RVNC) United States $0.888B 0.00
Cara Therapeutics (CARA) United States $0.879B 0.00
CytomX Therapeutics (CTMX) United States $0.848B 0.00
Acorda Therapeutics (ACOR) United States $0.845B 17.62
UNITY Biotechnology (UBX) $0.834B 0.00
Heska (HSKA) United States $0.834B 71.73
InflaRx (IFRX) Germany $0.814B 0.00
Amarin (AMRN) Ireland $0.807B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.779B 0.00
Dynavax Technologies (DVAX) United States $0.764B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.761B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.722B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.715B 0.00
Epizyme (EPZM) United States $0.688B 0.00
Abeona Therapeutics (ABEO) United States $0.657B 0.00
Fate Therapeutics (FATE) United States $0.652B 0.00
Scholar Rock Holding (SRRK) United States $0.646B 0.00
Verastem (VSTM) United States $0.645B 0.00
Kura Oncology (KURA) United States $0.638B 0.00
ANI Pharmaceuticals (ANIP) United States $0.633B 12.54
UROGEN PHARMA (URGN) Israel $0.619B 0.00
ObsEva SA (OBSV) Switzerland $0.615B 0.00
Anika Therapeutics (ANIK) United States $0.598B 25.14
Replimune (REPL) United States $0.592B 0.00
Arcus Biosciences (RCUS) United States $0.592B 0.00
MiMedx (MDXG) United States $0.586B 25.14
Mesoblast (MESO) Australia $0.579B 0.00
Vericel (VCEL) United States $0.573B 0.00
BeyondSpring (BYSI) United States $0.570B 0.00
Zealand Pharma (ZEAL) Denmark $0.569B 0.00
GTx (GTXI) United States $0.540B 0.00
Novavax (NVAX) United States $0.536B 0.00
Aduro Biotech (ADRO) United States $0.534B 0.00
Stemline Therapeutics (STML) United States $0.534B 0.00
AC Immune SA (ACIU) Switzerland $0.530B 0.00
Arbutus Biopharma (ABUS) Canada $0.529B 0.00
Prothena (PRTA) Ireland $0.526B 0.00
Sorrento Therapeutics (SRNE) United States $0.508B 87.00
Five Prime Therapeutics (FPRX) United States $0.492B 0.00
MediciNova (MNOV) United States $0.469B 0.00
Senesco Technologies (ELOX) United States $0.465B 0.00
Cytokineticsorporated (CYTK) United States $0.464B 0.00
Zymeworks (ZYME) Canada $0.463B 0.00
Eidos Therapeutics (EIDX) United States $0.457B 0.00
RA PHARMCTL INC (RARX) United States $0.455B 0.00
Kindred Biosciences (KIN) United States $0.455B 0.00
Inovio Pharmaceuticals (INO) United States $0.446B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.445B 0.00
Merus (MRUS) Netherlands $0.435B 0.00
Syros Pharmaceuticals (SYRS) United States $0.431B 0.00
Evelo Biosciences (EVLO) United States $0.431B 0.00
Sinovac Biotech (SVA) China $0.429B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.427B 0.00
Osiris Therapeutics (OSIR) United States $0.402B 0.00
ResTORbio (TORC) United States $0.398B 0.00
Albireo Pharma (ALBO) United States $0.393B 0.00
Magenta Therapeutics (MGTA) United States $0.391B 0.00
Kezar Life Sciences (KZR) United States $0.383B 0.00
Kadmon Holdings (KDMN) United States $0.378B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.369B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.367B 0.00
Adverum Biotechnologies (ADVM) United States $0.367B 0.00
PDL BioPharma (PDLI) United States $0.342B 4.80
AVEO Pharmaceuticals (AVEO) United States $0.342B 0.00
Unum Therapeutics (UMRX) United States $0.340B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.335B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.333B 0.00
Synlogic (SYBX) United States $0.331B 0.00
Cellular Biomedicine (CBMG) United States $0.331B 0.00
MeiraGTx Holdings (MGTX) United States $0.315B 0.00
Selecta Biosciences (SELB) United States $0.315B 0.00
Seres Therapeutics (MCRB) United States $0.302B 0.00
Liquidia Technologies (LQDA) United States $0.302B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.302B 0.00
ADMA Biologics Inc (ADMA) United States $0.300B 0.00
BioTime (BTX) United States $0.297B 0.00
Celcuity (CELC) United States $0.296B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.289B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.285B 0.00
Celyad SA (CYAD) Belgium $0.282B 0.00
Mersana Therapeutics (MRSN) United States $0.282B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.278B 0.00
MannKind (MNKD) United States $0.265B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.264B 0.00
Kala Pharmaceuticals (KALA) United States $0.264B 0.00
Athersys (ATHX) United States $0.259B 0.00
Axovant Sciences (AXON) United Kingdom $0.255B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.249B 0.00
Menlo Therapeutics (MNLO) United States $0.245B 0.00
NantKwest (NK) United States $0.241B 0.00
Kamada (KMDA) Israel $0.238B 18.44
TOCAGEN INC (TOCA) United States $0.228B 0.00
Idera Pharmaceuticals (IDRA) United States $0.217B 0.00
Agenus (AGEN) United States $0.216B 0.00
Allena Pharmaceuticals (ALNA) United States $0.216B 0.00
Enzo Biochem (ENZ) United States $0.214B 0.00
ChromaDex (CDXC) United States $0.206B 0.00
Palatin Technologies (PTN) United States $0.206B 8.50
Clearside Biomedical (CLSD) United States $0.201B 0.00
Compugen (CGEN) Israel $0.197B 0.00
Protagonist Therapeutics (PTGX) United States $0.197B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.187B 0.00
Strongbridge Biopharma (SBBP) United States $0.187B 0.00
Spero Therapeutics (SPRO) United States $0.185B 0.00
Cue Biopharma (CUE) United States $0.184B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.184B 0.00
Cohbar (CWBR) United States $0.180B 0.00
Signal Genetics (MGEN) United States $0.176B 0.00
Mustang Bio (MBIO) United States $0.173B 0.00
Constellation Pharmaceuticals (CNST) United States $0.167B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.167B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.167B 0.00
Krystal Biotech (KRYS) United States $0.165B 0.00
Cerecor (CERC) United States $0.165B 19.67
Syndax Pharmaceuticals (SNDX) United States $0.163B 0.00
Monster Digital (INNT) United States $0.162B 0.00
Eleven Biotherapeutics (SESN) United States $0.160B 0.00
BioDelivery Sciences (BDSI) United States $0.156B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.154B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.152B 0.00
Pluristem Therapeutics (PSTI) Israel $0.150B 0.00
Provention Bio (PRVB) United States $0.149B 0.00
Pfenex (PFNX) United States $0.148B 0.00
OVID THERAPEUTC (OVID) United States $0.146B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.145B 0.00
Organovo Holdings (ONVO) United States $0.136B 0.00
Checkpoint Therapeutics (CKPT) United States $0.136B 0.00
XOMA (XOMA) United States $0.136B 14.34
PSivida (EYPT) United States $0.130B 0.00
Tapimmune (TPIV) United States $0.128B 0.00
BioXcel Therapeutics (BTAI) United States $0.126B 0.00
Trevena (TRVN) United States $0.126B 0.00
Motif Bio Plc (MTFB) United States $0.125B 0.00
Intec Pharma (NTEC) Israel $0.125B 0.00
Cidara Therapeutics (CDTX) United States $0.116B 0.00
Vaccinex (VCNX) United States $0.115B 0.00
Catalyst Biosciences (CBIO) United States $0.113B 0.00
VBI Vaccines (VBIV) United States $0.113B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.112B 0.00
Aptevo Therapeutics (APVO) United States $0.109B 0.00
Cel-Sci (CVM) United States $0.104B 0.00
XBiotech (XBIT) United States $0.103B 0.00
Anavex Life Sciences (AVXL) United States $0.103B 0.00
ARIDIS PHARMACT (ARDS) United States $0.099B 0.00
Alcobra (ARCT) United States $0.099B 0.00
Leap Therapeutics (LPTX) United States $0.099B 0.00
Neothetics (EVFM) United States $0.098B 0.00
ScPharmaceuticals (SCPH) United States $0.095B 0.00
Fortress Biotech (FBIO) United States $0.090B 0.00
Aptose Biosciences (APTO) Canada $0.088B 0.00
NewLink Genetics (NLNK) United States $0.087B 0.00
Axsome Therapeutics (AXSM) United States $0.087B 0.00
Ophthotech (OPHT) United States $0.085B 0.55
Proteostasis Therapeutics (PTI) United States $0.085B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.083B 0.00
Orgenesis (ORGS) United States $0.082B 0.00
Evogene (EVGN) Israel $0.081B 0.00
Cocrystal Pharma (COCP) United States $0.080B 0.00
Prima BioMed (IMMP) Australia $0.080B 0.00
Alimera Sciences (ALIM) United States $0.078B 0.00
VolitionRX (VNRX) Singapore $0.077B 0.00
Sophiris Bio (SPHS) United States $0.077B 0.00
Applied Genetic Technologies (AGTC) United States $0.077B 0.00
Protalix BioTherapeutics (PLX) Israel $0.077B 0.00
Asterias Biotherapeutics (AST) United States $0.075B 0.00
Chiasma (CHMA) United States $0.074B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.073B 0.00
Oncolytics Biotech (ONCY) Canada $0.073B 0.00
Novelion Therapeutics (NVLN) Canada $0.072B 0.00
OncoSec Medical (ONCS) United States $0.069B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.069B 0.00
Bellerophon Therapeutics (BLPH) United States $0.068B 0.00
Celldex Therapeutics (CLDX) United States $0.068B 0.00
TRACON Pharmaceuticals (TCON) United States $0.067B 0.00
Oncobiologics (ONS) United States $0.064B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.060B 0.00
CorMedix Inc (CRMD) United States $0.059B 0.00
Caladrius Biosciences (CLBS) United States $0.059B 0.00
Entera Bio (ENTX) Israel $0.059B 0.00
Curis (CRIS) United States $0.055B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.055B 0.00
Celsion (CLSN) United States $0.051B 0.00
VIVUS (VVUS) United States $0.050B 0.00
Aileron Therapeutics (ALRN) United States $0.049B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Zosano Pharma (ZSAN) United States $0.047B 0.00
Eyenovia (EYEN) United States $0.046B 0.00
AZURRX BIOPHARM (AZRX) United States $0.045B 0.00
Moleculin Biotech (MBRX) United States $0.045B 0.00
Advaxis (ADXS) United States $0.042B 0.00
BioPharmX (BPMX) United States $0.039B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.038B 0.00
GENPREX INC (GNPX) United States $0.036B 0.00
Proteon Therapeutics (PRTO) United States $0.036B 0.00
CytRx (CYTR) United States $0.036B 0.00
AquaBounty Technologies (AQB) United States $0.034B 0.00
VistaGen Therapeutics (VTGN) United States $0.034B 0.00
Gemphire Therapeutics (GEMP) United States $0.032B 0.00
Vical (VICL) United States $0.030B 0.00
VTv Therapeutics (VTVT) United States $0.028B 0.00
Cellect Biotechnology (APOP) Israel $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.027B 55.00
Benitec Biopharma (BNTC) Australia $0.026B 0.00
Soligenix (SNGX) United States $0.026B 0.00
OvaScience (OVAS) United States $0.025B 0.00
Arsanis (ASNS) United States $0.024B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.024B 0.00
RestorGenex (DFFN) United States $0.023B 0.00
ATyr Pharma (LIFE) United States $0.023B 0.00
Cleveland BioLabs (CBLI) United States $0.022B 0.00
Edge Therapeutics (EDGE) United States $0.022B 0.00
Adial Pharmaceuticals (ADIL) United States $0.021B 0.00
Galena Biopharma (SLS) United States $0.021B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Pulmatrix (PULM) United States $0.020B 0.00
Vital Therapies (VTL) United States $0.018B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Prana Biotechnology (PRAN) Australia $0.017B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Neuralstem (CUR) United States $0.016B 0.00
Histogenics (HSGX) United States $0.016B 0.00
AmpliPhi Biosciences (APHB) United States $0.014B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.014B 5.25
Titan Pharmaceuticals (TTNP) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
IBio (IBIO) United States $0.010B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.010B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Synthetic Biologics (SYN) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Stellar Biotechnologies (SBOT) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Aytu Bioscience (AYTU) United States $0.005B 0.00
Oragenics (OGEN) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00